Showing results (1431-1440 of 1,588) with videos related to
Sort By:
Pageof 159
NPJ Vaccines|February 18, 2022
BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trialJoshua Gillard, Bastiaan A Blok, Daniel R Garza, et al.Allergy|July 4, 2015
First successful reduction of clinical allergenicity of food by genetic modification: Mal d 1-silenced apples cause fewer allergy symptoms than the wild-type cultivarA E J Dubois, G Pagliarani, R M Brouwer, et al.AIDS (London, England)|April 2, 2025
Dolutegravir plus lamivudine downregulates cellular stress responses versus three-drug HIV RegimensVictoria Rios-Vazquez, Wilhelm A J W Vos, Marc J T Blaauw, et al.Plos Neglected Tropical Diseases|February 19, 2016
Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained?Sake J de Vlas, Wilma A Stolk, Epke A le Rutte, et al.Infection Control and Hospital Epidemiology|April 5, 2011
Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study)I Willemsen, S Elberts, C Verhulst, et al.Viruses|April 27, 2024
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART StrategiesWilhelm A J W Vos, Nadira Vadaq, Vasiliki Matzaraki, et al.The Journal of Infectious Diseases|February 13, 2019
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy SubjectsEkta Lachmandas, Clare Eckold, Julia Böhme, et al.Familial Cancer|January 5, 2019
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortJ J Bakhuizen, F B Hogervorst, M E Velthuizen, et al.BMC Health Services Research|December 26, 2025
Development of BreeZe: a self-management support intervention for burn survivors informed by evidence, theory, and stakeholder co-creationSven J G Geelen, Sharon L Blok, Anuschka S Niemeijer, et al.Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.Pageof 159